No Subsidies for Gender Transition Procedures Act
- Bill Number
- S. 1551
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-05-01: Read twice and referred to the Committee on Finance.
- Last Updated
- 2025-12-05T22:55:22Z
AI-Generated Summary
Purpose
The legislation, titled the "No Subsidies for Gender Transition Procedures Act," aims to prevent federal tax deductions and funding for medical procedures related to gender transition. It defines these procedures based on biological sex (male or female, determined by reproductive functions at conception) and excludes them from various federal health programs and tax benefits, while allowing exceptions for certain medically necessary treatments unrelated to gender identity.
Key Provisions
- Tax Deduction Denial (Section 2): Amends the Internal Revenue Code to exclude "gender transition procedures" from qualifying as deductible medical expenses. These include hormonal treatments (e.g., puberty blockers, high-dose hormones like testosterone or estrogen to change appearance) and surgeries (e.g., mastectomy, vaginoplasty, phalloplasty, or removal of healthy body parts to align with a non-biological gender identity).
- Exclusions: Does not apply to treatments for disorders of sex development (e.g., ambiguous genitalia due to genetic conditions like 46 XX or XY chromosomal variations), infections/injuries from prior procedures, life-threatening physical conditions, reversal surgeries, precocious puberty treatment, or male circumcision.
- Effective for tax years beginning after enactment.
- Medicaid Funding Prohibition (Section 3): Amends the Social Security Act to bar federal Medicaid payments for specified gender transition procedures, including the same hormonal and surgical interventions listed above. States cannot receive federal matching funds for these services or related program administration.
- Uses the same definitions and exclusions as the tax provision.
- Applies to services provided on or after enactment.
- CHIP Funding Prohibition for Minors (Section 4): Amends the Social Security Act to prohibit federal Children's Health Insurance Program (CHIP) payments for gender transition procedures on individuals under 18. This includes blocking funds for state plans or coverage purchases that include such procedures.
- References the same definitions from Medicaid provisions.
- Applies to services provided on or after enactment.
- Medicare Funding Prohibition (Section 5): Amends the Social Security Act to exclude gender transition procedures from Medicare coverage, adding them to the list of non-reimbursable items and services.
- Applies to items and services provided on or after enactment.
- Exclusion from Essential Health Benefits (Section 6): Amends the Affordable Care Act to prevent gender transition procedures from being included in the list of essential health benefits that health insurance plans must cover. The Secretary of Health and Human Services cannot add or revise benefits to include them.
Significant Changes to Existing Law
- Tax Code: Adds a new exclusion under Section 213(d) for medical expense deductions, narrowing what counts as "medical care" by specifically targeting gender transition interventions.
- Social Security Act (Medicaid, CHIP, Medicare): Inserts prohibitions on federal funding for these procedures, expanding lists of excluded services (e.g., adding new paragraphs to Sections 1903(i), 2105(c), and 1862(a)). This shifts costs entirely to individuals or states without federal support.
- Affordable Care Act: Modifies essential health benefits rules to explicitly bar coverage of gender transition procedures, limiting their inclusion in standard insurance packages.
These changes introduce biologically based definitions of "sex," "male," and "female," which differ from some existing laws that recognize gender identity.
Potential Impacts
- On Citizens: Individuals seeking gender transition procedures (e.g., transgender people) will face higher out-of-pocket costs, as they lose tax deductions and federal insurance coverage through Medicaid, CHIP, Medicare, or ACA plans. This could limit access, especially for low-income, elderly, or minor populations.
- On Government Agencies: The Internal Revenue Service (IRS) will enforce new tax rules, potentially increasing administrative workload for audits. The Centers for Medicare & Medicaid Services (CMS) will oversee funding restrictions, leading to reduced federal expenditures on these procedures but possible increases in compliance monitoring for states.
- On International Relations: No direct impacts, as the bill focuses on domestic health policy and funding.
Main Stakeholders Affected
- Transgender Individuals and Families: Primary group impacted, as they may lose financial support for treatments aligned with their gender identity.
- Healthcare Providers: Doctors, clinics, and hospitals offering these procedures could see reduced reimbursements, affecting service availability.
- Federal and State Governments: Taxpayers and agencies like IRS and CMS bear enforcement costs; states administering Medicaid/CHIP may need to adjust programs or cover more with state funds.
- Insurers and Employers: Health plans under ACA must exclude these benefits, potentially influencing private coverage decisions.
Notable Legal, Constitutional, or Political Implications
- Legal: The bill's detailed definitions and exclusions could lead to litigation over what qualifies as a "gender transition procedure," including disputes on medical necessity or discrimination under laws like the Americans with Disabilities Act (if gender dysphoria is treated as a disability).
- Constitutional: May raise equal protection challenges under the 14th Amendment, as it differentiates treatment based on gender identity versus biological sex; courts could scrutinize if it unduly burdens access to healthcare.
- Political: Highlights debates on federal involvement in gender-affirming care, potentially influencing state-level policies and broader discussions on healthcare equity and personal autonomy. The bill was introduced by Senators Marshall, Ricketts, Cassidy, and Lee, signaling partisan divides.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Sen. Ricketts, Pete [R-NE], Sen. Cassidy, Bill [R-LA], Sen. Lee, Mike [R-UT]
Recent Actions
- 2025-05-01: Read twice and referred to the Committee on Finance.
- 2025-05-01: Introduced in Senate
Bill Versions
- No Subsidies for Gender Transition Procedures Act — issued 2025-05-01 — PDF (17 pages)